HDAC 4/5‐HMGB 1 signalling mediated by NADPH oxidase activity contributes to cerebral ischaemia/reperfusion injury
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Histone deacetylases (HDAC s)‐mediated epigenetic mechanisms play critical roles in the homeostasis of histone acetylation and gene transcription. HDAC inhibitors have displayed neuroprotective properties in animal models for various neurological diseases including Alzheimer's disease and ischaemic stroke. However, some studies have also reported that HDAC enzymes exert protective effects in several pathological conditions including ischaemic stress. The mixed results indicate the specific roles of each HDAC protein in different diseased states. However, the subtypes of HDAC s associated with ischaemic stroke keep unclear. Therefore, in this study, we used an in vivo middle cerebral artery occlusion (MCAO) model and in vitro cell cultures by the model of oxygen glucose deprivation to investigate the expression patterns of HDAC s and explore the roles of individual HDAC s in ischaemic stroke. Our results showed that inhibition of NADPH oxidase activity ameliorated cerebral ischaemia/reperfusion (I/R) injury and among Zn 2+‐dependent HDAC s, HDAC 4 and HDAC 5 were significantly decreased both in vivo and in vitro, which can be reversed by NADPH oxidase inhibitor apocynin. We further found that both HDAC 4 and HDAC 5 increased cell viability through inhibition of HMGB 1, a central mediator of tissue damage following acute injury, expression and release in PC 12 cells. Our results for the first time provide evidence that NADPH oxidase‐mediated HDAC 4 and HDAC 5 expression contributes to cerebral ischaemia injury via HMGB 1 signalling pathway, suggesting that it is important to elucidate the role of individual HDAC s within the brain, and the development of HDAC inhibitors with improved specificity is required to develop effective therapeutic strategies to treat stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ischemic Cell Death in Brain Neurons
Lipton, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1431 · Cited by 3,043 · cited 1×
“Although DND exhibits distinct morphological features from apoptosis, the molecular mechanisms involved in the apoptotic process may contribute to delayed neuronal death [50].”
BackgroundSustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780
Multiple roles of HDAC inhibition in neurodegenerative conditions
Chuang, D.-M., Leng, Y., Marinova, Z., Kim, H.-J., & Chiu, C.-T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.002 · Cited by 676 · cited 1×
“Reports have indicated that some Zn-dependent HDACs protect neurons and that inhibition of HDACs activity contributes to the promotion of neuronal death in neurodegenerative disorders rather than beneficial effects [8].”
BackgroundClass II histone deacetylases: versatile regulators
Verdin, E., Dequiedt, F., & Kasler, H. G. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00073-8 · Cited by 664 · cited 1×
“HDACs are a family of enzymes, which compete for control of the acetylation of lysine residues making up the histones with histone acetyltransferases (HATs), determining the post-translational acetylation status of chromatin and a number of other non-histone proteins [4].”
BackgroundHistone Deacetylase 5 Epigenetically Controls Behavioral Adaptations to Chronic Emotional Stimuli
Renthal, W., Maze, I., Krishnan, V., Covington, H. E., Xiao, G., Kumar, A., Russo, S. J., Graham, A., Tsankova, N., Kippin, T. E., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.09.032 · Cited by 599
Histone deacetylases as regulators of inflammation and immunity
Shakespear, M. R., Halili, M. A., Irvine, K. M., Fairlie, D. P., & Sweet, M. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.04.001 · Cited by 546
Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity
Kim, D., Frank, C. L., Dobbin, M. M., Tsunemoto, R. K., Tu, W., Peng, P. L., Guan, J.-S., Lee, B.-H., Moy, L. Y., Giusti, P., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.015 · Cited by 286
Vascular mechanisms in the pathogenesis of stroke.
Sierra, C., Coca, A., & Schiffrin, E. L. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0195-x · Cited by 162 · cited 1×
“Despite considerable studies have demonstrated that multiple pathogenic mechanisms are involved in ischaemic stroke, including inflammation, oxidative stress, excitotoxicity, calcium overload, apoptosis and disruption of the blood–brain barrier [1], the pre-clinical protective agents targeting a specific pathway faile…”
BackgroundVenkataramani, V., Rossner, C., Iffland, L., Schweyer, S., Tamboli, I. Y., Walter, J., Wirths, O., & Bayer, T. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057836 · Cited by 133 · cited 1×
“There is accumulating evidence that HDAC inhibitors exhibit neuroprotective and neuroregenerative properties in animal models of various neurological diseases including Alzheimer’s disease and ischaemic stroke [6, 7].”
Background
Cited by
NLRP3 Deficiency Ameliorates Neurovascular Damage in Experimental Ischemic Stroke
Yang, F., Wang, Z., Wei, X., Han, H., Meng, X., Zhang, Y., Shi, W., Li, F., Xin, T., Pang, Q., et al. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.242 · Cited by 422
Self-citationLiao, Y., Cheng, J., Kong, X., Li, S., Li, X., Zhang, M., Zhang, H., Yang, T., Dong, Y., Li, J., et al. (2020) · Theranostics · doi:10.7150/thno.47651 · Cited by 348
“Increasing evidence has shown that inhibition of HDACs promotes endogenous neuronal regeneration and protects neuronal cells from I/R-induced apoptosis [29, 30, 32].”
Self-citationArriazu, E., Ge, X., Leung, T.-M., Magdaleno, F., Lopategi, A., Lu, Y., Kitamura, N., Urtasun, R., Theise, N., Antoine, D. J., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310752 · Cited by 144
Role of histone deacetylases and their inhibitors in neurological diseases
Zhang, L.-Y., Zhang, S.-Y., Wen, R., Zhang, T.-N., & Yang, N. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107410 · Cited by 84
β-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy
Liu, J., Li, Q. X., Wang, X. J., Zhang, C., Duan, Y. Q., Wang, Z. Y., Zhang, Y., Yu, X., Li, N. J., Sun, J. P., et al. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.89 · Cited by 62
“For overexpressions of β-arrestin-1 and β-arrestin-2, podocytes were transfected with pCMV6-β-arrestin-1 or pCMV6-β-arrestin-2 plasmids by Lipofectamine 2000 as described.(48)”
MethodSelf-citation
Metadata
- Authors
- He, M., Zhang, B., Wei, X., Wang, Z., Fan, B., Du, P., Zhang, Y., Jian, W., Chen, L., Wang, L., Fang, H., Li, X., Wang, P., & Yi, F.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2013-03-11
- Volume
- 17
- Issue
- 4
- Pages
- 531-542
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- OpenAlex
- W1965923704
- Cited by
- 73
- References
- 9
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HDAC 4/5‐HMGB 1 signalling mediated by NADPH oxidase activity contributes to cerebral ischaemia/reperfusion injury. https://app.cochat.ai/papers/10.1111/jcmm.12040
- The paper
- He, M., Zhang, B., Wei, X., Wang, Z., Fan, B., Du, P., Zhang, Y., Jian, W., Chen, L., Wang, L., Fang, H., Li, X., Wang, P., & Yi, F. (2013). HDAC 4/5‐HMGB 1 signalling mediated by NADPH oxidase activity contributes to cerebral ischaemia/reperfusion injury. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.12040
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.